Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Acura Pharmaceuticals Company Profile (NASDAQ:ACUR)

Consensus Ratings for Acura Pharmaceuticals (NASDAQ:ACUR) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.75 (65.09% upside)

Analysts' Ratings History for Acura Pharmaceuticals (NASDAQ:ACUR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/3/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
5/28/2014MLV & Co DowngradeBuy -> Hold$2.00 -> $1.00ViewTweet This Rating  Share This Rating on StockTwits
5/22/2014Roth CapitalInitiated CoverageBuy$2.50ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014MLV & Co Lower Price Target$2.25 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014MLV & Co Boost Price Target$2.00 -> $2.25ViewTweet This Rating  Share This Rating on StockTwits
8/29/2013MLV & Co Lower Price TargetBuy$4.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2013MLV & Co Initiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
5/14/2013Roth CapitalInitiated CoverageBuy$4.50ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2012 forward)